Kidney Stones Clinical Trial
Official title:
Pilot Study : Effect of Sodium Thiosulfate on Urine Chemistries of Hypercalciuric Stone Formers
Sodium thiosulfate may be useful to prevent recurrence of calcium-containing kidney stones. It will be studied in people with high amounts of urine calcium.
The investigators study is designed as a pilot study to study the effect of STS on urine chemistries in stone formers and normal controls. It is expected to continue for a duration of 1 year and will have two groups: 20 normal controls, who are healthy subjects without known kidney disease or nephrolithiasis, and 20 subjects with documented recurrent nephrolithiasis and hypercalciuria. Patients will be recruited from Dr Goldfgarb's stone clinic at VA Hospital and controls would be voluntary participants from NYU School of Medicine. Subjects who are pregnant or nursing, taking alcohol or drugs, have known CKD or are unable to give consent would be excluded from the study. Any diuretics or citrate containing drugs would be held for a period of 2 weeks during the study period to achieve washout of the effects of those drugs on urine chemistries. Oral STS 10mmol (10ml of 25% STS) BID will be administered to both groups for 7 days; four 24 hour urine collections, 2 prior and 2 at the end of the study, would be done with all participants. A diet diary would be maintained by subjects concomitantly during the study periods. The investigators then plan to compare the two groups in terms of urine chemistries to detect any changes in these parameters with thiosulfate administration. Based on prior animal experiments and human studies with STS the investigators anticipate that it would have a favorable effect on the supersaturation of Ca oxalate/phosphate and therefore its long term use would be helpful in preventing nephrolithiasis. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02547805 -
Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Secondary Hyperoxaluria and Kidney Stones Over 28 Days
|
Phase 2 | |
Completed |
NCT02579161 -
Trial of Randomized Antibiotic Administration in Percutaneous Nephrolithotomy
|
Phase 3 | |
Completed |
NCT01187745 -
Study to Look for Artifact on Computed Tomography (CT) Representing Kidney Stones
|
N/A | |
Withdrawn |
NCT00875823 -
International Registry for Primary Hyperoxaluria
|
N/A | |
Completed |
NCT05519150 -
Donors With Nephrolithiasis at the Time of Transplant Evaluation (DONATE). Long Term Follow-up.
|
||
Recruiting |
NCT02522689 -
Comparison of Ultra-mini PCNL and Micro PCNL
|
N/A | |
Recruiting |
NCT01514032 -
Extracorporal Shockwave Lithotripsy Versus Retrograde Intrarenal Surgery for the Treatment of Kidney Stones
|
N/A | |
Completed |
NCT00873054 -
Percutaneous Nephrolithotomy Versus Extracorporeal Shock Wave Lithotripsy
|
N/A | |
Completed |
NCT00765128 -
Intravenous Ketorolac for Postoperative Pain in Percutaneous Nephrolithotomy
|
Phase 4 | |
Withdrawn |
NCT00583258 -
A Randomized Study of Whether Alfuzosin(Xatral) Helps in the Passage of Kidney Stones
|
N/A | |
Active, not recruiting |
NCT03630926 -
Evaluation of the NV-VPAC1 Prostate Cancer (PCa) Urine Diagnostic Test in Subjects With Biopsy-confirmed Prostate Cancer, Benign Prostatic Hypertrophy, or Bladder/Kidney Stones.
|
||
Not yet recruiting |
NCT02214836 -
Ultrasound Imaging of Kidney Stones and Lithotripsy
|
N/A | |
Completed |
NCT03095885 -
A Pilot Study of Oxalate Absorption in Secondary Hyperoxaluria
|
N/A | |
Completed |
NCT01330940 -
Effect of Diet Orange Soda on Urinary Lithogenicity
|
N/A | |
Recruiting |
NCT00489723 -
Is There is a Role of Prophylactic Therapy With Tamsulosin Before Extracorporeal Shock Wave Lithotripsy to Avoid Development of Steinstrasse ?
|
N/A | |
Recruiting |
NCT05417568 -
Oxalate-Driven Host Responses in Kidney Stone Disease
|
N/A | |
Recruiting |
NCT02375295 -
Struvite Stones Antibiotic Study
|
Phase 4 | |
Enrolling by invitation |
NCT02408211 -
Preoperative Antibiotic PNL Study
|
Phase 4 | |
Withdrawn |
NCT01560091 -
Differential Effect of Silodosin Versus Tamsulosin on Stone Clearance After Extra-corporeal Shock Wave Lithotripsy
|
Phase 3 | |
Completed |
NCT00857090 -
Pharmacokinetic, Safety and Efficacy Study of OMS201 in Subjects Undergoing Retrograde Ureteroscopic Removal of Upper Urinary Tract Stones
|
Phase 1/Phase 2 |